Citations for
1MTA1, VIM
Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients.
Karamagkiolas S, Giotakis I, Kyrodimos E, Giotakis EI, Kataki A, Karagianni F, Lazaris AM.
Am J Otolaryngol 40(4):487-493. doi: 10.1016/j.amjoto.2019.04.002. Epub 2019 Apr 3. 2019
2TRIM56, VIM
The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.
Zhao L, Zhang P, Su XJ, Zhang B.
J Cell Physiol 233(3):2420-2425. doi: 10.1002/jcp.26114. Epub 2017 Sep 12. 2018
3FBLN1, VIM
Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma.
Holmila R, Sklias A, Muller DC, Degli Esposti D, Guilloreau P, Mckay J, Sangrajrang S, Srivatanakul P, Hainaut P, Merle P, Herceg Z, Nogueira da Costa A.
PLoS One 12(3):e0174265. doi: 10.1371/journal.pone.0174265. eCollection 2017. 2017
4CDH2, INVS, MMP2, MMP9, VIM
Inversin correlates with the malignant phenotype of non-small cell lung cancer and promotes the invasiveness of lung cancer cells.
Jiang GY, Zhang Y, Zhang XP, Lin XY, Yu JH, Wang EH.
Tumour Biol 39(6):1010428317691177. doi: 10.1177/1010428317691177. 2017
5FSCN1, NSMCE3, VIM
Identification of Novel MAGE-G1-Interacting Partners in Retinoic Acid-Induced P19 Neuronal Differentiation Using SILAC-Based Proteomics.
Liu Y, Chen Y, Lin S, Yang S, Liu S.
Sci Rep 7:44699. doi: 10.1038/srep44699. 2017
6VIM
Vimentin as a poor prognostic factor for triple-negative breast cancer.
Yamashita N, Tokunaga E, Kitao H, Hisamatsu Y, Taketani K, Akiyoshi S, Okada S, Aishima S, Morita M, Maehara Y.
J Cancer Res Clin Oncol Cancer Res Clin Oncol. 2013 Jan 26. [Epub ahead of print] 2013
7PPARG, VIM
Cytoskeletal protein vimentin interacts with and regulates peroxisome proliferator-activated receptor gamma via a proteasomal degradation process.
Tsai YC, Tsai SH, Chang EY, Hee SW, Chen WH, Lee SC, Chuang LM.
J Cell Biochem Cell Biochem. 2013 Jan 7. doi: 10.1002/jcb.24497. [Epub ahead of print] 2013
8VIM
Vimentin DNA methylation predicts survival in breast cancer.
Ulirsch J, Fan C, Knafl G, Wu MJ, Coleman B, Perou CM, Swift-Scanlan T.
Breast Cancer Res Treat 137(2):383-96. doi: 10.1007/s10549-012-2353-5. Epub 2012 Dec 13. 2013
9VIM
The Intermediate Filament Vimentin Mediates MicroRNA miR-378 Function in Cellular Self-renewal by Regulating the Expression of the Sox2 Transcription Factor.
Deng Z, Du WW, Fang L, Shan SW, Qian J, Lin J, Qian W, Ma J, Rutnam ZJ, Yang BB.
J Biol Chem 288(1):319-31. doi: 10.1074/jbc.M112.418830. Epub 2012 Nov 7. 2013
10MMP9, TIMP2, VIM
Immunohistochemical expression of MMP-9, TIMP-2, E-cadherin and vimentin in ameloblastomas and their implication in the local aggressive behavior of these tumors.
Florescu A, Mărgăritescu C, Simionescu CE, Stepan A.
Rom J Morphol Embryol 53(4):975-84. 2012
11DCN, VIM
The dermatan sulfate proteoglycan decorin modulates α2β1 integrin and the vimentin intermediate filament system during collagen synthesis.
Jungmann O, Nikolovska K, Stock C, Schulz JN, Eckes B, Riethmüller C, Owens RT, Iozzo RV, Seidler DG.
PLoS One 7(12):e50809. doi: 10.1371/journal.pone.0050809. Epub 2012 Dec 3. 2012
12ATF4, VIM
Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis.
Lian N, Lin T, Liu W, Wang W, Li L, Sun S, Nyman JS, Yang X.
J Biol Chem 287(43):35975-84. doi: 10.1074/jbc.M112.372458. Epub 2012 Sep 4. 2012
13VIM
A role for vimentin in Crohn disease.
Henderson P, Wilson DC, Satsangi J, Stevens C.
Autophagy 8(11):1695-6. doi: 10.4161/auto.21690. Epub 2012 Aug 28. 2012
14ALOX15, VIM
Characterization of a human 12/15-lipoxygenase promoter variant associated with atherosclerosis identifies vimentin as a promoter binding protein.
Samanta S, Anderson K, Moran S, Hawke D, Gorenstein D, Fornage M.
PLoS One 7(8):e42417. doi: 10.1371/journal.pone.0042417. Epub 2012 Aug 7. 2012
15NOD2, VIM
The intermediate filament protein, vimentin, is a regulator of NOD2 activity.
Stevens C, Henderson P, Nimmo ER, Soares DC, Dogan B, Simpson KW, Barrett JC; International Inflammatory Bowel Disease Genetics Consortium, Wilson DC, Satsangi J.
Gut ut. 2012 Jul 10. [Epub ahead of print] 2012
16MMP14, VIM
Calpain-mediated vimentin cleavage occurs upstream of MT1-MMP membrane translocation to facilitate endothelial sprout initiation.
Kwak HI, Kang H, Dave JM, Mendoza EA, Su SC, Maxwell SA, Bayless KJ.
Angiogenesis 15(2):287-303. doi: 10.1007/s10456-012-9262-4. Epub 2012 Mar 11. 2012
17DES, FBXO32, MSTN, VIM
Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting.
Lokireddy S, Wijesoma IW, Sze SK, McFarlane C, Kambadur R, Sharma M.
Am J Physiol Cell Physiol 303(5):C512-29. doi: 10.1152/ajpcell.00402.2011. Epub 2012 Jun 6. 2012
18AKT1, VIM
Vimentin is a novel AKT1 target mediating motility and invasion.
Zhu QS, Rosenblatt K, Huang KL, Lahat G, Brobey R, Bolshakov S, Nguyen T, Ding Z, Belousov R, Bill K, Luo X, Lazar A, Dicker A, Mills GB, Hung MC, Lev D.
Oncogene 30(4):457-70. Epub 2010 Sep 20. 2011
19LARP6, VIM
A novel role of vimentin filaments: binding and stabilization of collagen mRNAs.
Challa AA, Stefanovic B.
Mol Cell Biol 31(18):3773-89. Epub 2011 Jul 11. 2011
20VIM, YY1
CpG methylation prevents YY1-mediated transcriptional activation of the vimentin promoter.
Sekimata M, Murakami-Sekimata A, Homma Y.
Biochem Biophys Res Commun 414(4):767-72. doi: 10.1016/j.bbrc.2011.09.155. Epub 2011 Oct 7. 2011
21VASP, VIM
Vimentin expression influences flow dependent VASP phosphorylation and regulates cell migration and proliferation.
Lund N, Henrion D, Tiede P, Ziche M, Schunkert H, Ito WD.
Biochem Biophys Res Commun 395(3):401-6. Epub 2010 Apr 9.PMID: 20382123 2010
22CZP2, VIM
Dominant cataract formation in association with a vimentin assembly disrupting mutation.
Müller M, Bhattacharya SS, Moore T, Prescott Q, Wedig T, Herrmann H, Magin TM.
Hum Mol Genet 18(6):1052-7. Epub 2009 Jan 6. 2009
23VIM
Vimentin filaments support extension of tubulin-based microtentacles in detached breast tumor cells.
Whipple RA, Balzer EM, Cho EH, Matrone MA, Yoon JR, Martin SS.
Cancer Res 68(14):5678-88. 2008
24VIM
Vimentin supports mitochondrial morphology and organization.
Tang HL, Lung HL, Wu KC, Le AH, Tang HM, Fung MC.
Biochem J 410(1):141-6.PMID: 17983357 2008
25VIM
Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion.
McInroy L, Määttä A.
Biochem Biophys Res Commun 360(1):109-14. Epub 2007 Jun 15. 2007
26GFAP, SYNM, VIM
Synemin is expressed in reactive astrocytes in neurotrauma and interacts differentially with vimentin and GFAP intermediate filament networks.
Jing R, Wilhelmsson U, Goodwill W, Li L, Pan Y, Pekny M, Skalli O.
J Cell Sci 120(Pt 7):1267-77. Epub 2007 Mar 13. 2007
27VIM
Novel functions of vimentin in cell adhesion, migration, and signaling.
Ivaska J, Pallari HM, Nevo J, Eriksson JE.
Exp Cell Res 313(10):2050-62. Epub 2007 Apr 14. Review. 2007
28ACTG1, COL1A1, COL1A2, COL2A1, COL9A1, DIO2, HSPA8, IBSP, IGF1, KAT6B, OGN, POU3F4, RBMS3, VIM, ZIC2
Cloning, characterization, and mRNA expression analysis of novel human fetal cochlear cDNAs.
Luijendijk MW, van de Pol TJ, van Duijnhoven G, den Hollander AI, ten Caat J, van Limpt V, Brunner HG, Kremer H, Cremers FP.
Genomics 82(4):480-90. 2003
29VIM
An antisilencer element is involved in the transcriptional regulation of the human vimentin gene.
Izmailova ES, et al.
Gene 230(1):111-20. 1999
30VIM
Genes occupy a fixed and symmetrical position on sister chromatids.
Baumgarter M, et al.
Cell 64 : 761-766. 1991
31VIM
BclI RFLP for the human vimentin gene.
Marcus EM, et al.
Nucleic Acids Res 16 : 9068. 1988
32VIM
The gene encoding human vimentin is located on the short arm of chromosome 10.
Ferrari S, Cannizzaro LA, Battini R, Huebner K, Baserga R.
Am J Hum Genet 41 : 616-626. 1987
33VIM
Human vimentin gene (VIM) is in chromosome 10.
Quax W, et al.
(HGM8) Cytogenet Cell Genet 40 : 727. 1985